MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases

Promoter methylation of CHFR gene in gastric carcinoma tissues detected using two methods

(2012) Zhao-Dong Cheng et al.   Chinese Journal of Cancer

The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk

(2011) Marian Y. Williams-Brown et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

TP53 Mutations in Endometrial Cancers

(2010) Aneta Janiec-Jankowska et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

AKT1 pleckstrin homology domain E17K activating mutation in endometrial carcinoma

(2009) Yoram Cohen et al.   GYNECOLOGIC ONCOLOGY

Absence of MGMT promoter methylation in endometrial cancer

(2008) B.J. Rimel et al.   GYNECOLOGIC ONCOLOGY

Methylation pattern of theO6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis

(2008) Takeshi Nagasaka et al.   INTERNATIONAL JOURNAL OF CANCER

Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen

(2008) Julia Turbiner et al.   MODERN PATHOLOGY

Quantifiable mRNA transcripts for tamoxifen-metabolising enzymes in human endometrium

(2008) Maneesh N. Singh et al.   TOXICOLOGY